A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma
Clinical trial NCT07283796 · RECRUITING
Trial details
- NCT number
- NCT07283796
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-28
- Primary completion
- 2027-12-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.